Communicable Disease Control Directorate, WA Health, Perth, WA, Australia.
Med J Aust. 2011 Jan 17;194(2):68-72. doi: 10.5694/j.1326-5377.2011.tb04170.x.
To determine antibody levels and estimate incidence of infection with pandemic (H1N1) 2009 influenza in children and pregnant women during the 2009 winter in Western Australia.
DESIGN, SETTING AND PARTICIPANTS: Two cross-sectional serosurveys using stored specimens collected for unrelated pathology testing, from before and after (3 August to 30 November 2009) circulation of the pandemic virus, and before commencement of the pandemic vaccination program. Specimens were from three groups: children aged 1-4 years, older children and teenagers aged 5-19 years, and pregnant women aged 21-45 years. The groups were geographically representative of the WA population.
Reactivity against pandemic (H1N1) 2009 and seasonal A(H1N1) influenza viruses measured using haemagglutination inhibition (HI) assays.
Antibody titres were determined for 648 individuals in the prepandemic period and 736 in the postpandemic period. In the prepandemic period, HI titres ≥ 40 against the pandemic virus were found in 0 (95% CI, 0.0%-1.6%) children aged 1-4 years, 8.3% (95% CI, 5.3%-12.7%) of older children and teenagers, and 4.5% (95% CI, 2.4%-8.3%) of pregnant women. In postpandemic specimens collected from 1 September 2009 (when influenza activity had declined to near-baseline levels), estimated infection rates (subtracting prepandemic levels) were 25.4% (95% CI for difference, 18.6%-33.4%) in 1-4-year-old children, 39.4% (95% CI, 29.8%-48.5%) in older children and teenagers, and 10.2% (95% CI, 4.1%-17.1%) in pregnant women.
A quarter of preschool children and about 40% of school-aged children and older teenagers had serological evidence of pandemic influenza infection during winter 2009, indicating high levels of mild or asymptomatic infection. The infection rate in pregnant women was much lower. The high infection rates in children help explain the reduced impact of the pandemic virus during the 2010 winter. Augmented by vaccination, there should be sufficiently high levels of immunity in the Australian population to significantly reduce the impact of the virus in future influenza seasons.
在 2009 年西澳大利亚州冬季,确定儿童和孕妇中流行(H1N1)2009 流感的抗体水平并估计感染发生率。
设计、地点和参与者:使用为无关病理检测而收集的储存标本进行了两项横断面血清学调查,分别在大流行病毒传播之前(2009 年 8 月 3 日至 11 月 30 日)和大流行疫苗接种计划开始之前进行。标本来自三组:1-4 岁儿童、5-19 岁较大儿童和青少年以及 21-45 岁孕妇。这些组在地理上代表了西澳大利亚州的人群。
使用血凝抑制(HI)测定法测量针对大流行(H1N1)2009 年和季节性 A(H1N1)流感病毒的反应性。
在大流行前时期确定了 648 个人的抗体滴度,在大流行后时期确定了 736 个人的抗体滴度。在大流行前时期,1-4 岁儿童中发现针对大流行病毒的 HI 滴度≥40 的为 0(95%CI,0.0%-1.6%),较大儿童和青少年中为 8.3%(95%CI,5.3%-12.7%),孕妇中为 4.5%(95%CI,2.4%-8.3%)。在 2009 年 9 月 1 日(当时流感活动已降至接近基线水平)采集的大流行后标本中,估计的感染率(减去大流行前水平)为 1-4 岁儿童中 25.4%(95%CI 差异,18.6%-33.4%),较大儿童和青少年中为 39.4%(95%CI,29.8%-48.5%),孕妇中为 10.2%(95%CI,4.1%-17.1%)。
在 2009 年冬季,四分之一的学龄前儿童和约 40%的学龄儿童和青少年有大流行流感感染的血清学证据,表明轻度或无症状感染的发生率很高。孕妇的感染率要低得多。儿童中的高感染率有助于解释大流行病毒在 2010 年冬季的影响降低。通过疫苗接种增强免疫力,澳大利亚人群中应具有足够高的免疫水平,以大大降低该病毒在未来流感季节的影响。